VasoLead (2012) Ltd. Report issue

For profit Phase 2
Founded: Tel Aviv Israel (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2015
NCT02496845
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

papaverine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1